SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-15-037813
Filing Date
2015-10-16
Accepted
2015-10-16 10:19:21
Documents
1
Period of Report
2015-07-21

Document Format Files

Seq Description Document Type Size
1 FORM 4 doc1.html 4  
1 FORM 4 doc1.xml 4 7961
  Complete submission text file 0001140361-15-037813.txt   9369
Mailing Address C/O AGY THERAPEUTICS INC 290 UTAH AVE SOUTH SAN FRANCISCO CA 94080
Business Address
LADD CYNTHIA J (Reporting) CIK: 0001217596 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37587 | Film No.: 151161291

Mailing Address 343 OYSTER POINT BLVD. SUITE 100 SOUTH SAN FRANCISCO CA 94080
Business Address 343 OYSTER POINT BLVD. SUITE 100 SOUTH SAN FRANCISCO CA 94080 650.515.3185
CytomX Therapeutics, Inc. (Issuer) CIK: 0001501989 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations